Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Orexin Receptor Antagonists: A New Concept In CNS Disorders?
John Gatfield, Catherine Brisbare‐Roch, François Jenck, et al.
ChemMedChem (2010) Vol. 5, Iss. 8, pp. 1197-1214
Closed Access | Times Cited: 65

Showing 26-50 of 65 citing articles:

Similar role of mPFC orexin-1 receptors in the acquisition and expression of morphine- and food-induced conditioned place preference in male rats
Shole Jamali, Shahram Zarrabian, Abbas Haghparast
Neuropharmacology (2021) Vol. 198, pp. 108764-108764
Closed Access | Times Cited: 16
Disubstituted piperidines as potent orexin (hypocretin) receptor antagonists
Rong Jiang, Xinyi Song, Purva Bali, et al.
Bioorganic & Medicinal Chemistry Letters (2012) Vol. 22, Iss. 12, pp. 3890-3894
Open Access | Times Cited: 22
Why Does Sleep Stop Migraine?
Marcelo E. Bigal, Richard Hargreaves
Current Pain and Headache Reports (2013) Vol. 17, Iss. 10
Closed Access | Times Cited: 22
Truncated Orexin Peptides: Structure–Activity Relationship Studies
Nadezhda German, Ann M. Decker, Brian P. Gilmour, et al.
ACS Medicinal Chemistry Letters (2013) Vol. 4, Iss. 12, pp. 1224-1227
Open Access | Times Cited: 21
Design, synthesis, and structure–activity relationships of a series of novel N-aryl-2-phenylcyclopropanecarboxamide that are potent and orally active orexin receptor antagonists
Yu Yoshida, Taro Terauchi, Yoshimitsu Naoe, et al.
Bioorganic & Medicinal Chemistry (2014) Vol. 22, Iss. 21, pp. 6071-6088
Closed Access | Times Cited: 20
Discovery of piperidine ethers as selective orexin receptor antagonists (SORAs) inspired by filorexant
Izzat T. Raheem, Michael J. Breslin, Joseph G. Bruno, et al.
Bioorganic & Medicinal Chemistry Letters (2014) Vol. 25, Iss. 3, pp. 444-450
Closed Access | Times Cited: 20
Synthesis and characterization of a new Positron emission tomography probe for orexin 2 receptors neuroimaging
Ping Bai, Yan Liu, Yulong Xu, et al.
Bioorganic Chemistry (2022) Vol. 123, pp. 105779-105779
Open Access | Times Cited: 10
G Proteins, p60TRP, and Neurodegenerative Diseases
Klaus Heese
Molecular Neurobiology (2013) Vol. 47, Iss. 3, pp. 1103-1111
Closed Access | Times Cited: 19
Radiosynthesis of [11C]BBAC and [11C]BBPC as potential PET tracers for orexin2 receptors
Fei Liu, Vattoly J. Majo, Jaya Prabhakaran, et al.
Bioorganic & Medicinal Chemistry Letters (2012) Vol. 22, Iss. 6, pp. 2172-2174
Closed Access | Times Cited: 18
Orexin receptor antagonists – a patent review (2010 to August 2014)
Christoph Boss
Expert Opinion on Therapeutic Patents (2014) Vol. 24, Iss. 12, pp. 1367-1381
Closed Access | Times Cited: 18
Role of medial hypothalamic orexin system in panic, phobia and hypertension
Aline Rezende Abreu, Andrei I. Molosh, Philip L. Johnson, et al.
Brain Research (2018) Vol. 1731, pp. 145942-145942
Open Access | Times Cited: 18
Discovery of HTL6641, a dual orexin receptor antagonist with differentiated pharmacodynamic properties
J.A. Christopher, Sarah J. Aves, Jason Brown, et al.
MedChemComm (2015) Vol. 6, Iss. 5, pp. 947-955
Closed Access | Times Cited: 17
Discovery of Highly Potent Dual Orexin Receptor Antagonists via a Scaffold‐Hopping Approach
Bibia Heidmann, John Gatfield, Catherine Roch, et al.
ChemMedChem (2016) Vol. 11, Iss. 19, pp. 2132-2146
Closed Access | Times Cited: 17
Orexin research: patent news from 2016
Christoph Boss, Catherine Roch
Expert Opinion on Therapeutic Patents (2017) Vol. 27, Iss. 10, pp. 1123-1133
Closed Access | Times Cited: 17
The importance of the 6- and 7-positions of tetrahydroisoquinolines as selective antagonists for the orexin 1 receptor
David A. Perrey, Ann M. Decker, Jun‐Xu Li, et al.
Bioorganic & Medicinal Chemistry (2015) Vol. 23, Iss. 17, pp. 5709-5724
Open Access | Times Cited: 17
Discovery of substituted lactams as novel dual orexin receptor antagonists. Synthesis, preliminary structure–activity relationship studies and efforts towards improved metabolic stability and pharmacokinetic properties. Part 1
Thierry Sifferlen, Amandine Boller, Audrey Chardonneau, et al.
Bioorganic & Medicinal Chemistry Letters (2014) Vol. 24, Iss. 4, pp. 1201-1208
Closed Access | Times Cited: 16
Diaryl urea analogues of SB-334867 as orexin-1 receptor antagonists
David A. Perrey, Brian P. Gilmour, Scott P. Runyon, et al.
Bioorganic & Medicinal Chemistry Letters (2011) Vol. 21, Iss. 10, pp. 2980-2985
Open Access | Times Cited: 17
Effect of 1-Substitution on Tetrahydroisoquinolines as Selective Antagonists for the Orexin-1 Receptor
David A. Perrey, Nadezhda German, Ann M. Decker, et al.
ACS Chemical Neuroscience (2015) Vol. 6, Iss. 4, pp. 599-614
Open Access | Times Cited: 14
Structure–activity relationship studies and sleep-promoting activity of novel 1-chloro-5,6,7,8-tetrahydroimidazo[1,5-a]pyrazine derivatives as dual orexin receptor antagonists. Part 2
Thierry Sifferlen, Ralf Koberstein, Emmanuelle Cottreel, et al.
Bioorganic & Medicinal Chemistry Letters (2013) Vol. 23, Iss. 13, pp. 3857-3863
Closed Access | Times Cited: 13
Orexin Receptor Antagonists
J.A. Christopher
Pharmaceutical Patent Analyst (2012) Vol. 1, Iss. 3, pp. 329-346
Closed Access | Times Cited: 13
Small-molecule Antagonists of the Orexin Receptors
J.A. Christopher
Pharmaceutical Patent Analyst (2014) Vol. 3, Iss. 6, pp. 625-638
Closed Access | Times Cited: 12
Orexin Receptor Antagonists in Development for Insomnia and CNS Disorders
Scott D. Kuduk, Christopher J. Winrow, Paul J. Coleman
Annual reports in medicinal chemistry (2013), pp. 73-87
Closed Access | Times Cited: 11
Synthesis, structure–activity relationship studies, and identification of novel 5,6,7,8-tetrahydroimidazo[1,5-a]pyrazine derivatives as dual orexin receptor antagonists. Part 1
Thierry Sifferlen, Ralf Koberstein, Emmanuelle Cottreel, et al.
Bioorganic & Medicinal Chemistry Letters (2013) Vol. 23, Iss. 7, pp. 2212-2216
Closed Access | Times Cited: 11
Synthesis and Evaluation of Orexin-1 Receptor Antagonists with Improved Solubility and CNS Permeability
David A. Perrey, Ann M. Decker, Yanan Zhang
ACS Chemical Neuroscience (2017) Vol. 9, Iss. 3, pp. 587-602
Open Access | Times Cited: 10
Discovery and optimisation of 1-acyl-2-benzylpyrrolidines as potent dual orexin receptor antagonists
Jodi T. Williams, John Gatfield, Catherine Roch, et al.
MedChemComm (2015) Vol. 6, Iss. 6, pp. 1054-1064
Closed Access | Times Cited: 9

Scroll to top